| Q33651168 | "Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases |
| Q50148053 | "INTERMED": a method to assess health service needs. II. Results on its validity and clinical use. |
| Q33745744 | A confirmatory bifactor analysis of the Hospital Anxiety and Depression Scale in an Italian community sample |
| Q51017954 | A confirmatory factor analysis of the Hospital Anxiety and Depression Scale in coronary care patients following acute myocardial infarction. |
| Q50917880 | A preliminary psychometric evaluation of the Hospital Anxiety and Depression Scale (HADS) in 963 people living with a spinal cord injury. |
| Q39987863 | A psychometric evaluation of the Hospital Anxiety and Depression Scale in cardiac patients: addressing factor structure and gender invariance |
| Q73634547 | A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population |
| Q37928506 | Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis |
| Q34778970 | Affective disorders in advanced cancer |
| Q28296405 | Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapies |
| Q77335198 | An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer |
| Q59811771 | An application of escape theory to binge eating |
| Q24812242 | An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer |
| Q57640304 | Anpassungsstörungen bei internistischen Erkrankungen |
| Q50855154 | Anxiety and depression among HIV-infected heterosexuals--a report from India. |
| Q44965451 | Anxiety, depression and quality of life in colorectal cancer patients |
| Q51090657 | Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? |
| Q53370620 | Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. |
| Q48374918 | Assessment and treatment of depression in the cancer patient |
| Q25257175 | Assessment of the structure of the Hospital Anxiety and Depression Scale in musculoskeletal patients |
| Q46032225 | Association between cancer stigma and depression among cancer survivors: a nationwide survey in Korea. |
| Q37157563 | BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy |
| Q40153778 | Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer |
| Q40938010 | Breast cancer survivors' perceived medical communication competence and satisfaction with care at the end of treatment |
| Q36081743 | Can mood disorder in women with breast cancer be identified preoperatively? |
| Q50713915 | Cancer-related fatigue in breast cancer patients after surgery: a multicomponent model using partial least squares-path modeling. |
| Q34356815 | Cardiac vagal control and theoretical models of co-occurring depression and anxiety: a cross-sectional psychophysiological study of community elderly |
| Q42698439 | Caregivers' quality of life and psychological health in response to functional, cognitive, neuropsychiatric and social deficits of patients with brain tumour: protocol for a cross-sectional study |
| Q35572264 | Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies |
| Q47687159 | Clinical and demographic profile of cancer patients in a consultation-liaison psychiatric service. |
| Q34219482 | Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project |
| Q36440120 | Clinical practice guidelines for the management of psychosocial distress at the end of life |
| Q40704065 | Common psychiatric disorders in cancer patients. I. Adjustment disorders and depressive disorders |
| Q44733656 | Comorbidity between personality disorders and depressive symptomatology in women: A cross-sectional study of three different transitional life stages. |
| Q51082090 | Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. |
| Q71417104 | Criterion-based validation of the EORTC QLQ-C36 in advanced melanoma: the CIPS questionnaire and proxy raters |
| Q36696783 | Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer |
| Q44960202 | Decreasing Psychological Distress in Cancer Inpatients Using FLEX Care®: A Pilot Study |
| Q48906921 | Defining hospital anxiety and depression scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings. |
| Q74461180 | Depression among hospitalised medically ill patients: a two-stage screening study |
| Q33708177 | Depression in breast cancer patients: the need for treatment |
| Q44321759 | Depression is associated with some patient-perceived cosmetic changes, but not with radiotherapy-induced late toxicity, in long-term breast cancer survivors |
| Q60621982 | Depression, psychosocial variables and occurrence of life events among patients with cancer |
| Q43633362 | Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management |
| Q43752554 | Depressive symptoms and quality of life in home-care-assisted cancer patients |
| Q43688008 | Desire for formal psychological support among caregivers of patients with cancer: prevalence and implications for screening their needs |
| Q51914841 | Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. |
| Q59566082 | Developing a cancer-specific geriatric assessment |
| Q37332745 | Development and pilot-testing of a Decision Aid for use among Chinese women facing breast cancer surgery |
| Q51094562 | Development of an aromatherapy service at a Cancer Centre. |
| Q51919462 | Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation. |
| Q47913812 | Dimensionality of the Chinese hospital anxiety depression scale in psychiatric outpatients: Mokken scale and factor analyses |
| Q48986438 | Dimensionality of the hospital anxiety and depression scale (HADS) in cardiac patients: comparison of Mokken scale analysis and factor analysis |
| Q47817677 | Distress in suspected lung cancer patients following rapid and standard diagnostic programs: a prospective observational study. |
| Q48737122 | Distress trajectories at the first year diagnosis of breast cancer in relation to 6 years survivorship. |
| Q43782529 | Do spirituality and faith make a difference? Report from the Southern European Psycho-Oncology Study Group |
| Q80955256 | Does psychological characteristic influence physicians' communication styles? Impact of physicians' locus of control on interviews with a cancer patient and a relative |
| Q51951706 | Early psychological adjustment in breast cancer patients: a prospective study. |
| Q91734116 | Effectiveness of a therapeutic patient education program in improving cancer pain management: EFFADOL, a stepped-wedge randomised controlled trial |
| Q64257134 | Effectiveness of therapy group in women with localized breast cancer |
| Q49056399 | Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy |
| Q40108348 | Evaluating the factor structure, item analyses, and internal consistency of hospital anxiety and depression scale in Iranian infertile patients |
| Q48031567 | Examination of the construct validity of the Swedish version of Hospital Anxiety and Depression Scale in breast cancer patients |
| Q96298603 | Factor structure and reliability of Persian version of hospital anxiety and depression scale in patients with breast cancer survivors |
| Q24805945 | Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients |
| Q37204735 | Factor structure of the Hospital Anxiety and Depression Scale in Japanese psychiatric outpatient and student populations |
| Q81841950 | Factors that influence physicians' detection of distress in patients with cancer: can a communication skills training program improve physicians' detection? |
| Q38274205 | Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. |
| Q48225991 | Fear of recurrence: a case report of a woman breast cancer survivor with GAD treated successfully by CBT. |
| Q34424657 | Feasibility study of a randomized controlled trial of a telephone‐delivered problem‐solving–occupational therapy intervention to reduce participation restrictions in rural breast cancer survivors undergoing chemotherapy |
| Q41113385 | Fractalkine (C-X3-C motif chemokine ligand 1) as a potential biomarker for depression and anxiety in colorectal cancer patients. |
| Q46001891 | Funding consultation-liaison psychiatry via Medicare screening |
| Q42122788 | Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. |
| Q36622443 | How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? |
| Q37932467 | Identifying psychological morbidity among people with cancer using the Hospital Anxiety and Depression Scale: time to revisit first principles? |
| Q37862517 | Impact of a novel nurse-led prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results from a randomised, controlled trial |
| Q36649086 | Impact of medical specialists' locus of control on communication skills in oncological interviews. |
| Q41438678 | Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. |
| Q51777000 | Improving anxiety regulation in patients with breast cancer at the beginning of the survivorship period: a randomized clinical trial comparing the benefits of single-component and multiple-component group interventions. |
| Q74449112 | Individual quality of life in patients with leukaemia and lymphoma |
| Q36849057 | International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results |
| Q51991154 | Intrusive memories and depression in cancer patients. |
| Q51914229 | Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: a feasibility study. |
| Q50879373 | Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? |
| Q35982053 | Is group psychotherapy feasible for oncology outpatients attenders selected on the basis of psychological morbidity? |
| Q51080065 | Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care? |
| Q50952966 | Is there a correlation between spirituality and anxiety and depression in patients with advanced cancer? |
| Q39648473 | Limited validity of the Hospital Anxiety and Depression Scale (HADS) in dementia: evidence from a confirmatory factor analysis. |
| Q51935695 | Listen to the patient: quality of life of patients with recently diagnosed malignant cord compression in relation to their disability. |
| Q91302147 | Mindfulness-based cognitive therapy for psycho-oncology patients: an exploratory study |
| Q52167333 | Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program. |
| Q50033737 | Patient-Centered Care in Breast Cancer Genetic Clinics |
| Q45986916 | Patients attitudes towards sleep disturbances during chemotherapy. |
| Q50721629 | Perceived social support in Spanish cancer outpatients with psychiatric disorder. |
| Q50954604 | Perceptions of psychosis, coping, appraisals, and psychological distress in the relatives of patients with schizophrenia: an exploration using self-regulation theory. |
| Q41240853 | Personality traits and coping styles explain anxiety in lung cancer patients to a greater extent than other factors |
| Q36618146 | Predicting delayed anxiety and depression in patients with gastrointestinal cancer |
| Q51070782 | Predicting mood disorders in breast cancer patients. |
| Q47344808 | Predicting psychological distress in patients with leukaemia and lymphoma |
| Q50920541 | Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital. |
| Q46324032 | Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies |
| Q33768621 | Prevalence of emotional symptoms in Chilean oncology patients before the start of chemotherapy: potential of the distress thermometer as an ultra-brief screening instrument |
| Q44336972 | Prevalence of psychological distress and use of support services by cancer patients at Sydney hospitals |
| Q51976408 | Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. |
| Q36791086 | Primary extraosseous Ewing sarcoma of the lung in children |
| Q34278073 | Proinflammatory cytokines correlate with depression and anxiety in colorectal cancer patients. |
| Q70565394 | Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factors |
| Q43824293 | Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study |
| Q51965479 | Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. |
| Q33837252 | Psycho-oncology: where have we been? Where are we going? |
| Q47985982 | Psychodynamic interventions in cancer care I: psychometric results of a randomized controlled trial |
| Q41121642 | Psychological approaches to the management of pain in patients with advanced cancer |
| Q36431136 | Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors |
| Q51985872 | Psychological distress among cancer patients and informed consent. |
| Q36080540 | Psychological distress in head and neck cancer patients 7-11 years after curative treatment |
| Q47636762 | Psychological effects of cetuximab-induced cutaneous rash in advanced colorectal cancer patients |
| Q51914031 | Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. |
| Q51055765 | Psychological reactions in public melanoma screening. |
| Q36620102 | Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy |
| Q35738844 | Psychometric evaluation of the Hospital Anxiety and Depression Scale 3 months after acute lung injury |
| Q33942870 | Psychometric evaluation of the Hospital Anxiety and Depression Scale in a large community sample of adolescents in Hong Kong |
| Q90373792 | Psychometric properties of Short Form-36 Health Survey, EuroQol 5-dimensions, and Hospital Anxiety and Depression Scale in patients with chronic pain |
| Q51852491 | Psychometric properties of the Screening Inventory of Psychosocial Problems (SIPP) in Dutch cancer patients treated with radiotherapy. |
| Q79805988 | Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation |
| Q36615341 | Psychosocial difficulties, deprivation and cancer: three questionnaire studies involving 609 cancer patients |
| Q48703260 | Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation |
| Q52006594 | Psychosocial morbidity and adjustment to illness among long-term cancer survivors. A six-year follow-up study. |
| Q90261353 | Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study |
| Q77930887 | Quality of life assessment in the collaborative ocular melanoma study: design and methods. COMS-QOLS Report No. 1. COMS Quality of Life Study Group |
| Q33583279 | Quality-of-life assessment in health care research and practice |
| Q43758645 | Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy |
| Q51994339 | Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. |
| Q35338089 | Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease |
| Q33338620 | Rasch fit statistics and sample size considerations for polytomous data |
| Q74550158 | Relations between desire for early death, depressive symptoms and antidepressant prescribing in terminally ill patients with cancer |
| Q34022465 | Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients |
| Q33808649 | Reliability and validity of the Ethiopian version of the hospital anxiety and depression scale (HADS) in HIV infected patients |
| Q50961016 | Religious struggle and religious comfort in response to illness: health outcomes among stem cell transplant patients. |
| Q48300512 | Routine depression screening and diagnosing strategy for cancer inpatients |
| Q37514212 | Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review |
| Q51137330 | Screening for anxiety and depression in cancer patients: the effects of disease and treatment. |
| Q51939195 | Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. |
| Q52585762 | Screening for emotional disorders in patients with cancer using the Brief Symptom Inventory (BSI) and the BSI-18 versus a standardized psychiatric interview (the World Health Organization Composite International Diagnostic Interview). |
| Q35820240 | Screening for emotional distress in cancer patients: a systematic review of assessment instruments |
| Q45226621 | Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12. |
| Q35993398 | Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires |
| Q51095181 | Screening for psychological distress in Japanese cancer patients. |
| Q51701181 | Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer. |
| Q36611422 | Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory |
| Q77907264 | Seasonal affective disorder in an Arctic community |
| Q44379392 | Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology |
| Q48869413 | Sensitivity and specificity of the Distress Impact Thermometer for the detection of psychological distress among CRC survivors |
| Q58236651 | Sexual Functioning and Mood Among Long-Term Survivors of Clear-Cell Adenocarcinoma of the Vagina or Cervix |
| Q92180179 | Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial |
| Q36746707 | Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer |
| Q25256647 | Structural ambiguity of the Chinese version of the Hospital Anxiety and Depression Scale in patients with coronary heart disease |
| Q51946140 | Suffering and adaptation to cancer. What to measure and when to intervene. |
| Q45737694 | Suicide probability and psychological morbidity secondary to HIV infection: a control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HIV/HCV-seronegative injecting drug users. |
| Q48241308 | The Edinburgh cohort of HIV-positive drug users: the relationship between auditory P3 latency, cognitive function and self-rated mood |
| Q45843585 | The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan |
| Q50475495 | The Hospital Anxiety and Depression Scale (HAD) as a screening instrument in tinnitus evaluation. |
| Q48425616 | The ability of informal primary caregivers to accurately report cancer patients' difficulties. |
| Q47658815 | The burden of psychosocial morbidity related to cancer: patient and family issues |
| Q33921226 | The effect of aromatase inhibition on the cognitive function of older patients with breast cancer. |
| Q81592841 | The factor structure of the Hospital Anxiety and Depression Scale in older individuals with acquired amputations: a comparison of four models using confirmatory factor analysis |
| Q35387307 | The factor structure of the hospital anxiety and depression scale in orthopedic trauma patients |
| Q47564186 | The geriatric depression scale in palliative care |
| Q39530113 | The history of psychosocial screening among cancer patients |
| Q48627293 | The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer |
| Q51123997 | The prevalence and implications of elderly inpatients' desire for a formal psychological help at the start of cancer treatment. |
| Q43446520 | The prevalence of major depressive disorder and low self-esteem in medical inpatients |
| Q38430860 | The psychometric properties of cancer multisymptom assessment instruments: a clinical review |
| Q37329759 | The psychosocial evaluation of medically-ill inpatients - accordance between mental disorders and self-rated psychosocial distress. |
| Q51854475 | The structure of the Hospital Anxiety and Depression Scale in four cohorts of community-based, healthy older people: the HALCyon program. |
| Q47630487 | The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy |
| Q34113060 | The validity of the Hospital Anxiety and Depression Scale. An updated literature review |
| Q43812374 | Three-dimensional structure of the Hospital Anxiety and Depression Scale in a large French primary care population suffering from major depression |
| Q40788211 | Toward a comprehensive care of HIV patients: finding a strategy to detect depression in a Spanish HIV cohort. |
| Q48823408 | Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability. |
| Q52551121 | Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation. |
| Q47347667 | Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey |
| Q60621937 | Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients |
| Q41261945 | Use of the Hospital Anxiety and Depression Scale in Spanish caregivers. |
| Q36623307 | Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice |
| Q36091705 | Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival? |
| Q34247107 | Wording effects and the factor structure of the Hospital Anxiety & Depression Scale in HIV/AIDS patients on antiretroviral treatment in South Africa |
| Q80306329 | [Psychosocial counseling of skin cancer patients in these times of diagnosis related groups (DRG)] |
| Q38896845 | e-Therapy to reduce emotional distress in women undergoing assisted reproductive technology (ART): a feasibility randomized controlled trial |